Table 4.

Differential blood counts after termination of the cell-based therapy during chemoembolisation with Gemcitabine (Gem), Irinotecan (Irino), Epirubicin (Epi), Oxaliplatin (Oxa)

Date	08/06	09/06 Gem	11/06 Gem	01/07 Irino	03/07 Epi	04/07 Epi	07/07 Oxa	09/07	10/07
WBCs, lymphocytes, hemoglobin, thrombocytes after cell-based therapy
[Normal range] healthy donors (n = 6)
Leukocytes (G/l) [≥ 4]	6	7	7.6	9.9	6.4	6.3	3.4	3.3	3.0
Lymphocytes (%) [15–40%]	(11)	(9)	(6)	(7)	(8)	(7)	(9)	(13)	(13)
Hemoglobin (g/dl) [≥ 11]	11.7	11.2	12.3	12.5	11.2	10.2	10.3	11.1	11.7
Thrombocytes (G/l) [≥ 100]	232	239	255	189	357	347	126	115	145